255 related articles for article (PubMed ID: 8855805)
1. Hypercalcemia due to constitutive activity of the parathyroid hormone (PTH)/PTH-related peptide receptor: comparison with primary hyperparathyroidism.
Parfitt AM; Schipani E; Rao DS; Kupin W; Han ZH; Jüppner H
J Clin Endocrinol Metab; 1996 Oct; 81(10):3584-8. PubMed ID: 8855805
[TBL] [Abstract][Full Text] [Related]
2. A novel parathyroid hormone (PTH)/PTH-related peptide receptor mutation in Jansen's metaphyseal chondrodysplasia.
Schipani E; Langman C; Hunzelman J; Le Merrer M; Loke KY; Dillon MJ; Silve C; Jüppner H
J Clin Endocrinol Metab; 1999 Sep; 84(9):3052-7. PubMed ID: 10487664
[TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
4. Direct comparison of sustained infusion of human parathyroid hormone-related protein-(1-36) [hPTHrP-(1-36)] versus hPTH-(1-34) on serum calcium, plasma 1,25-dihydroxyvitamin D concentrations, and fractional calcium excretion in healthy human volunteers.
Horwitz MJ; Tedesco MB; Sereika SM; Hollis BW; Garcia-Ocaña A; Stewart AF
J Clin Endocrinol Metab; 2003 Apr; 88(4):1603-9. PubMed ID: 12679445
[TBL] [Abstract][Full Text] [Related]
5. Plasma intact parathyroid hormone (PTH) and PTH-related peptide in familial benign hypercalcemia: greater responsiveness to endogenous PTH than in primary hyperparathyroidism.
Firek AF; Kao PC; Heath H
J Clin Endocrinol Metab; 1991 Mar; 72(3):541-6. PubMed ID: 1997510
[TBL] [Abstract][Full Text] [Related]
6. Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia.
Schipani E; Langman CB; Parfitt AM; Jensen GS; Kikuchi S; Kooh SW; Cole WG; Jüppner H
N Engl J Med; 1996 Sep; 335(10):708-14. PubMed ID: 8703170
[TBL] [Abstract][Full Text] [Related]
7. Association between parathyroid hormone (PTH)/PTH-related peptide receptor gene polymorphism and the extent of bone mass reduction in primary hyperparathyroidism.
Kanzawa M; Sugimoto T; Kobayashi T; Kobayashi A; Chihara K
Horm Metab Res; 2000 Sep; 32(9):355-8. PubMed ID: 11014383
[TBL] [Abstract][Full Text] [Related]
8. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
9. Parathyroid hormone-related protein-(1--36) stimulates renal tubular calcium reabsorption in normal human volunteers: implications for the pathogenesis of humoral hypercalcemia of malignancy.
Syed MA; Horwitz MJ; Tedesco MB; Garcia-Ocaña A; Wisniewski SR; Stewart AF
J Clin Endocrinol Metab; 2001 Apr; 86(4):1525-31. PubMed ID: 11297578
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone-related protein induced coupled increases in bone formation and resorption markers for 7 years in a patient with malignant islet cell tumors.
Takeuchi Y; Fukumoto S; Nakayama K; Tamura Y; Yanagisawa A; Fujita T
J Bone Miner Res; 2002 May; 17(5):753-7. PubMed ID: 12009004
[TBL] [Abstract][Full Text] [Related]
11. Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia.
Jobert AS; Zhang P; Couvineau A; Bonaventure J; Roume J; Le Merrer M; Silve C
J Clin Invest; 1998 Jul; 102(1):34-40. PubMed ID: 9649554
[TBL] [Abstract][Full Text] [Related]
12. Pamidronate corrects the down-regulation of the renal parathyroid hormone (PTH)/PTH-related peptide (PTHrP) receptor mRNA in rats bearing Walker tumors.
Yaghoobian J; Morieux C; Denne MA; Bouizar Z; Ureña P; de Vernejoul MC
Horm Metab Res; 1998 May; 30(5):249-55. PubMed ID: 9660083
[TBL] [Abstract][Full Text] [Related]
13. The PTH/PTHrP receptor in Jansen's metaphyseal chondrodysplasia.
Calvi LM; Schipani E
J Endocrinol Invest; 2000 Sep; 23(8):545-54. PubMed ID: 11021773
[TBL] [Abstract][Full Text] [Related]
14. A form of Jansen's metaphyseal chondrodysplasia with limited metabolic and skeletal abnormalities is caused by a novel activating parathyroid hormone (PTH)/PTH-related peptide receptor mutation.
Bastepe M; Raas-Rothschild A; Silver J; Weissman I; Wientroub S; Jüppner H; Gillis D
J Clin Endocrinol Metab; 2004 Jul; 89(7):3595-600. PubMed ID: 15240651
[TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of the cyclic adenosine 3',5'-monophosphate signaling pathway by parathyroid hormone (PTH)/PTH-related peptide receptors mutated at the two loci for Jansen's metaphyseal chondrodysplasia.
Schipani E; Jensen GS; Pincus J; Nissenson RA; Gardella TJ; Jüppner H
Mol Endocrinol; 1997 Jun; 11(7):851-8. PubMed ID: 9178745
[TBL] [Abstract][Full Text] [Related]
16. Inverse agonism of amino-terminally truncated parathyroid hormone (PTH) and PTH-related peptide (PTHrP) analogs revealed with constitutively active mutant PTH/PTHrP receptors.
Gardella TJ; Luck MD; Jensen GS; Schipani E; Potts JT; Jüppner H
Endocrinology; 1996 Sep; 137(9):3936-41. PubMed ID: 8756569
[TBL] [Abstract][Full Text] [Related]
17. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
Christiansen P
APMIS Suppl; 2001; (102):1-52. PubMed ID: 11419022
[TBL] [Abstract][Full Text] [Related]
18. New insights on the pathogenesis of hypercalcemia in primary hyperparathyroidism.
Yonemura K; Suzuki H; Fujigaki Y; Hishida A
Am J Med Sci; 2000 Nov; 320(5):334-6. PubMed ID: 11093687
[TBL] [Abstract][Full Text] [Related]
19. G alpha q family members couple parathyroid hormone (PTH)/PTH-related peptide and calcitonin receptors to phospholipase C in COS-7 cells.
Offermanns S; Iida-Klein A; Segre GV; Simon MI
Mol Endocrinol; 1996 May; 10(5):566-74. PubMed ID: 8732687
[TBL] [Abstract][Full Text] [Related]
20. Calcium homeostasis and hyperparathyroidism: Nephrologic and endocrinologic points of view.
Lemoine S; Figueres L; Bacchetta J; Frey S; Dubourg L
Ann Endocrinol (Paris); 2022 Aug; 83(4):237-243. PubMed ID: 35598638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
